“BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors”., Bangla J Med, vol. 35, no. 20, p. 165, Jun. 2024, doi: 10.3329/bjm.v35i20.73432.